TD Asset Management
DYN icon

TD Asset Management’s Dyne Therapeutics DYN Stock Holding History

TD Asset Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.2M Buy
548,112
+18,800
+4% +$350K 0.01% 612
2026
Q1 		$9.6M Buy
529,312
+109,556
+26% +$1.89M 0.01% 655
2025
Q4 		$8.21M Buy
419,756
+399,374
+1,959% +$7.56M 0.01% 706
2025
Q3 		$258K Buy
+20,382
New +$232K ﹤0.01% 1210
2025
Q2 		– Sell
-21,656
Closed -$227K – 1213
2025
Q1 		$227K Sell
21,656
-50,374
-70% -$721K ﹤0.01% 1192
2024
Q4 		$1.7M Sell
72,030
-36,800
-34% -$1.09M ﹤0.01% 1045
2024
Q3 		$3.68M Sell
108,830
-43,380
-29% -$1.73M ﹤0.01% 862
2024
Q2 		$5.37M Buy
152,210
+77,410
+103% +$2.25M 0.01% 749
2024
Q1 		$2.12M Buy
+74,800
New +$1.69M ﹤0.01% 1003
2023
Q4 		– Sell
-23,000
Closed -$206K – 1407
2023
Q3 		$206K Buy
+23,000
New +$248K ﹤0.01% 1368
2023
Q2 		– Sell
-20,900
Closed -$241K – 1426
2023
Q1 		$241K Buy
+20,900
New +$271K ﹤0.01% 1365
2021
Q1 		– Sell
-27,586
Closed -$579K – 1510
2020
Q4 		$579K Hold
27,586
– – ﹤0.01% 1307
2020
Q3 		$557K Buy
+27,586
New +$605K ﹤0.01% 1214

Other funds holding DYN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

TD Asset Management's DYN Position: Q2 2026 in Review

TD Asset Management increased its Dyne Therapeutics (DYN) stake by 3.6% in Q2 2026, buying an estimated $350K and bringing the position to 548,112 shares worth $12.2M. The position accounts for 0.01% of the portfolio, ranked #612.

TD Asset Management first reported a position in DYN in Q3 2020 and has held it in 13 quarters since. 160 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • TD Asset Management held 548,112 shares of Dyne Therapeutics worth $12.2M as of Q2 2026.
  • TD Asset Management bought 18,800 Dyne Therapeutics shares in Q2 2026, an estimated $350K.
  • Dyne Therapeutics made up 0.01% of TD Asset Management's portfolio in Q2 2026, its #612 holding.
  • TD Asset Management first reported a position in Dyne Therapeutics in Q3 2020 and has held it in 13 quarters since.
  • 160 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.